意馬國際(00585.HK)盈喜:預期中期税前綜合溢利約2000萬港元
格隆匯7月19日丨意馬國際(00585.HK)公吿,公司預期於截至2022年6月30日止6個月期間,錄得未經審核除税前綜合溢利約2000萬港元,而截至2021年6月30日止期間則錄得相應未經審核除税前綜合溢利約1070萬港元。
董事會認為,公司未經審核除税前綜合溢利預期增加主要是由於:(i)分類為持作買賣上市股本投資公平值變動未變現虧損由上一期間錄得約2480萬港元減少至本期間約230萬港元;及(ii)並無上一期間錄得衍生財務工具公平值虧損及可換股債券利息開支分別約140萬港元及120萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.